Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8133114rdf:typepubmed:Citationlld:pubmed
pubmed-article:8133114lifeskim:mentionsumls-concept:C0005767lld:lifeskim
pubmed-article:8133114lifeskim:mentionsumls-concept:C0003374lld:lifeskim
pubmed-article:8133114lifeskim:mentionsumls-concept:C0024537lld:lifeskim
pubmed-article:8133114lifeskim:mentionsumls-concept:C0033126lld:lifeskim
pubmed-article:8133114lifeskim:mentionsumls-concept:C1306673lld:lifeskim
pubmed-article:8133114pubmed:issue4lld:pubmed
pubmed-article:8133114pubmed:dateCreated1994-4-18lld:pubmed
pubmed-article:8133114pubmed:abstractTextThe blood stage antimalarial efficacy of primaquine (0.25 mg of base/kg of body weight/day over 14 days) and chloroquine (25 mg of base/kg over 3 days) were compared in 85 adult Thai men with acute Plasmodium vivax malaria. Most (75%) had at least one malaria episode previously. Parasite clearance times after primaquine alone (n = 30) were slower than after chloroquine (n = 30) or combined chloroquine-primaquine (n = 25), but all patients had a satisfactory initial therapeutic response. P. vivax malaria recurred in 10 (17%) of 60 patients followed for > or = 2 months and Plasmodium falciparum malaria developed in another 5 (8%) without reexposure to infection. Recurrences occurred < or = 5 weeks after primaquine treatment (n = 4), suggesting recrudescence, whereas recurrences after chloroquine treatment (n = 6) occurred > or = 5 weeks later, suggesting relapse. Vivax malaria responds well initially to either primaquine or chloroquine. The blood stage antimalarial activity of primaquine may mask chloroquine resistance in combined regimens.lld:pubmed
pubmed-article:8133114pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8133114pubmed:languageenglld:pubmed
pubmed-article:8133114pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8133114pubmed:citationSubsetAIMlld:pubmed
pubmed-article:8133114pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8133114pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8133114pubmed:statusMEDLINElld:pubmed
pubmed-article:8133114pubmed:monthAprlld:pubmed
pubmed-article:8133114pubmed:issn0022-1899lld:pubmed
pubmed-article:8133114pubmed:authorpubmed-author:ClemensRRlld:pubmed
pubmed-article:8133114pubmed:authorpubmed-author:VanijanontaSSlld:pubmed
pubmed-article:8133114pubmed:authorpubmed-author:WhiteN JNJlld:pubmed
pubmed-article:8133114pubmed:authorpubmed-author:Pukrittayakam...lld:pubmed
pubmed-article:8133114pubmed:authorpubmed-author:ChantraAAlld:pubmed
pubmed-article:8133114pubmed:issnTypePrintlld:pubmed
pubmed-article:8133114pubmed:volume169lld:pubmed
pubmed-article:8133114pubmed:ownerNLMlld:pubmed
pubmed-article:8133114pubmed:authorsCompleteYlld:pubmed
pubmed-article:8133114pubmed:pagination932-5lld:pubmed
pubmed-article:8133114pubmed:dateRevised2010-8-25lld:pubmed
pubmed-article:8133114pubmed:meshHeadingpubmed-meshheading:8133114-...lld:pubmed
pubmed-article:8133114pubmed:meshHeadingpubmed-meshheading:8133114-...lld:pubmed
pubmed-article:8133114pubmed:meshHeadingpubmed-meshheading:8133114-...lld:pubmed
pubmed-article:8133114pubmed:meshHeadingpubmed-meshheading:8133114-...lld:pubmed
pubmed-article:8133114pubmed:meshHeadingpubmed-meshheading:8133114-...lld:pubmed
pubmed-article:8133114pubmed:meshHeadingpubmed-meshheading:8133114-...lld:pubmed
pubmed-article:8133114pubmed:meshHeadingpubmed-meshheading:8133114-...lld:pubmed
pubmed-article:8133114pubmed:meshHeadingpubmed-meshheading:8133114-...lld:pubmed
pubmed-article:8133114pubmed:meshHeadingpubmed-meshheading:8133114-...lld:pubmed
pubmed-article:8133114pubmed:meshHeadingpubmed-meshheading:8133114-...lld:pubmed
pubmed-article:8133114pubmed:meshHeadingpubmed-meshheading:8133114-...lld:pubmed
pubmed-article:8133114pubmed:meshHeadingpubmed-meshheading:8133114-...lld:pubmed
pubmed-article:8133114pubmed:meshHeadingpubmed-meshheading:8133114-...lld:pubmed
pubmed-article:8133114pubmed:meshHeadingpubmed-meshheading:8133114-...lld:pubmed
pubmed-article:8133114pubmed:meshHeadingpubmed-meshheading:8133114-...lld:pubmed
pubmed-article:8133114pubmed:year1994lld:pubmed
pubmed-article:8133114pubmed:articleTitleBlood stage antimalarial efficacy of primaquine in Plasmodium vivax malaria.lld:pubmed
pubmed-article:8133114pubmed:affiliationFaculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.lld:pubmed
pubmed-article:8133114pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8133114pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:8133114pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:8133114pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8133114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8133114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8133114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8133114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8133114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8133114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8133114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8133114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8133114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8133114lld:pubmed